CUPERTINO, Calif., July 10 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that it will present a corporate overview at
two upcoming life sciences conferences.
- Leerink Swann & Company/MEDA Corp Pain Roundtable Conference: Monday,
July 10, 2006 at the Le Parker Meridien, Hotel in New York, NY at
10:15 a.m. EDT.
- C.E. Unterberg, Towbin Emerging Growth Conference: Tuesday, July 11,
2006 at The Mandarin Oriental Hotel in New York, NY at 1:22 p.m. EDT.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )
A live audio webcast of the presentations will be available by accessing
DURECT’s homepage at http://www.www.durect.com and clicking “Investor Relations”.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company focused
on the development of pharmaceutical systems based on its proprietary drug
delivery platform technologies. The company is developing pharmaceutical
systems to deliver the right drug to the right place in the right amount at
the right time to treat chronic and episodic diseases and conditions.
SOURCE DURECT Corporation
CONTACT: Schond L. Greenway, Vice President, Investor Relations and
Strategic Planning of DURECT Corporation, +1-408-777-1417
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, email@example.com
Web site: http://www.www.durect.com/